Dafer RM, Tietjen GE, Rothrock JF, Vann RE, et al. Cardiovascular safety of dihydroergotamine mesylate delivered by precision olfactory delivery (INP104) for the acute treatment of migraine. Headache 2024 May 27. doi: 10.1111/head.14669.
PMID: 38800847